RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 148 filers reported holding RELAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $299 | -32.4% | 35,551 | +1.0% | 0.00% | -100.0% |
| Q2 2023 | $442 | -52.0% | 35,193 | -37.1% | 0.00% | 0.0% |
| Q1 2023 | $921 | -9.8% | 55,916 | -18.2% | 0.00% | 0.0% |
| Q4 2022 | $1,021 | -99.9% | 68,347 | -0.0% | 0.00% | -50.0% |
| Q3 2022 | $1,529,000 | +44.0% | 68,366 | +7.8% | 0.00% | +100.0% |
| Q2 2022 | $1,062,000 | -32.1% | 63,393 | +21.2% | 0.00% | -50.0% |
| Q1 2022 | $1,565,000 | +16.6% | 52,304 | +19.7% | 0.00% | +100.0% |
| Q4 2021 | $1,342,000 | -1.5% | 43,692 | +1.1% | 0.00% | 0.0% |
| Q3 2021 | $1,362,000 | -26.4% | 43,200 | -14.6% | 0.00% | -50.0% |
| Q2 2021 | $1,851,000 | +43.6% | 50,593 | +35.6% | 0.00% | +100.0% |
| Q1 2021 | $1,289,000 | +6.2% | 37,300 | +27.7% | 0.00% | 0.0% |
| Q4 2020 | $1,214,000 | -2.4% | 29,200 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $1,244,000 | – | 29,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 4,068,574 | $68,149,000 | 5.76% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $467,408,000 | 3.71% |
| BVF INC/IL | 4,384,805 | $73,445,000 | 3.55% |
| Boxer Capital, LLC | 2,669,132 | $44,708,000 | 2.83% |
| Nextech Invest Ltd. | 475,485 | $7,964,000 | 2.69% |
| EcoR1 Capital, LLC | 3,723,541 | $62,369,000 | 2.15% |
| HARBOURVEST PARTNERS LLC | 296,402 | $4,965,000 | 1.63% |
| Integral Health Asset Management, LLC | 436,262 | $7,307,000 | 1.50% |
| Alphabet Inc. | 1,568,753 | $26,277,000 | 1.43% |
| Fernwood Investment Management, LLC | 185,063 | $3,100,000 | 1.34% |